Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC...what's it going to take to break loose!!

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Jun 15, 2023 6:20am

222 Views

Post# 35497492

RE:RE:RE:RE:RE:ONC...what's it going to take to break loose!!

Matt seemed very confident to be able to bring lot a value to all shareholders in the coming months. He has a lot of money to make himself if he is able to do so. I Still think it's coming. PANC and car-t are probably what will bring the SP way higher. GL

<< Previous

Bullboard Posts

Next >>

Stockhouse DealRoom opens new Australian opportunities